Newport Beach, CA2 Active Studies

Multiple Sclerosis Clinical Trials in Newport Beach, CA

Find 2 actively recruiting multiple sclerosis clinical trials in Newport Beach, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,000
Enrolling

Recruiting Multiple Sclerosis Studies in Newport Beach

About Multiple Sclerosis Clinical Trials in Newport Beach

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 2 multiple sclerosis clinical trials recruiting participants in Newport Beach, CA. These studies are seeking a combined 1,000 participants. Research is being sponsored by Novartis Pharmaceuticals, Ocuphire Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Newport Beach — FAQ

Are there multiple sclerosis clinical trials in Newport Beach?

Yes, there are 2 multiple sclerosis clinical trials currently recruiting in Newport Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 2 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov